 Shares of OraSure Technologies Inc. OSUR, 5.09 gained 2.2 in premarket trading on Monday after the company said its COVID-19 rapid tests have now been authorized for children between the ages of 2 and 14 years old. The tests had previously received emergency use authorization from the Food and Drug Administration for use in teens and adults. 